Effectiveness of rituximab in neuromyelitis optica: a meta-analysis

Neuromyelitis optica (NMO) is a severe inflammatory autoimmune disorder of the central nervous system and often results in paralysis or blindness. Rituximab (RTX) is a mouse –human chimeric monoclonal antibody ...

Source: BMC Neurology - March 6, 2019 Category: Neurology Authors: Fulin Gao, Bingyan Chai, Cheng Gu, Ruipeng Wu, Tong Dong, Yuping Yao and Yi Zhang Tags: Research article Source Type: research